Global, regional, and national burden of asthma from 1990 to 2021: analysis of data from global disease burden in 2021.

IF 2.8 3区 医学 Q2 RESPIRATORY SYSTEM
Cong Hu, Shuxiong Nong, Yixin Chen, Lin Zhang, Yongfeng Chen, Chenang Liu, Ping Li, Chilin Liao, Meng Wu
{"title":"Global, regional, and national burden of asthma from 1990 to 2021: analysis of data from global disease burden in 2021.","authors":"Cong Hu, Shuxiong Nong, Yixin Chen, Lin Zhang, Yongfeng Chen, Chenang Liu, Ping Li, Chilin Liao, Meng Wu","doi":"10.1186/s12890-025-03816-5","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Asthma is one of the diseases that pose a serious threat to human health globally. The Global Burden of Disease (GBD) study from 1990 to 2021 conducted a comprehensive assessment of the prevalence, incidence, mortality, and Disability-Adjusted Life Years (DALY) of asthma. This study particularly focuses on the integration of prevalence data with other indicators and carries out stratified analyses at the global, regional, and national levels based on gender, age, and Socio-Demographic Index (SDI).</p><p><strong>Methods: </strong>The data for this study is drawn from the 2021 Global Burden of Disease (GBD) study, which provides comprehensive data on diseases, injuries, and risk factors. This study aims to explore the temporal trends of asthma and assess the dynamics of age-standardized prevalence rates (ASPR), incidence rates (ASIR), death rates (ASDR), and disability-adjusted life years (DALYs) for asthma, with the goal achieved by estimating the annual percentage change (EAPC) over the study period. The study conducted a detailed stratification based on gender, 20 age groups, 21 GBD regions, 204 countries and territories, and 5 SDI quintiles.</p><p><strong>Results: </strong>In 2021, asthma continued to impose a substantial burden on the global health landscape, with a total of 260479186.9 (227209547.5-297967236.9) cases and an ASPR of 3340.1 (2905.2-3832.2 per 100,000 people. The ASIR was 37864175.4 (31381241-46919993.7), translating to 516.7 (425.4-646.1) per 100,000 people. In 2021, the number of disability-adjusted life years (DALYs) attributed to asthma was 21422859.9 (16956877.7-26887091.7), and the ASDR was 264.6 (208.3-333.4) per 100,000 people. Analyzing regional disparities, it was observed that High SDI regions had the highest ASPR, and ASIR, while Low SDI regions had the lowest ASDR and Age-standardized DALY rates. Geographically, Kazakstan and Pakistan stood out with the high ASPR, and Papua New Guinea stood out with the highest ASDR, and Age-standardized DALY rates. Asthma primarily affects minors, with no significant difference between males and females. High BMI has emerged as the most important risk factor for asthma-related DALYs globally.</p><p><strong>Conclusion: </strong>This pattern indicates a complex relationship between socio-economic development and health outcomes. Regions with higher Socio-Demographic Index (SDI), which typically represent more developed areas, tend to have a higher prevalence of asthma but lower mortality rates and disease burden. These patterns highlight the necessity for low-income regions to learn from the targeted public health measures of high-income areas in developing asthma management plans, in order to address the inequalities in asthma outcomes.</p>","PeriodicalId":9148,"journal":{"name":"BMC Pulmonary Medicine","volume":"25 1","pages":"481"},"PeriodicalIF":2.8000,"publicationDate":"2025-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12538757/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMC Pulmonary Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s12890-025-03816-5","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Asthma is one of the diseases that pose a serious threat to human health globally. The Global Burden of Disease (GBD) study from 1990 to 2021 conducted a comprehensive assessment of the prevalence, incidence, mortality, and Disability-Adjusted Life Years (DALY) of asthma. This study particularly focuses on the integration of prevalence data with other indicators and carries out stratified analyses at the global, regional, and national levels based on gender, age, and Socio-Demographic Index (SDI).

Methods: The data for this study is drawn from the 2021 Global Burden of Disease (GBD) study, which provides comprehensive data on diseases, injuries, and risk factors. This study aims to explore the temporal trends of asthma and assess the dynamics of age-standardized prevalence rates (ASPR), incidence rates (ASIR), death rates (ASDR), and disability-adjusted life years (DALYs) for asthma, with the goal achieved by estimating the annual percentage change (EAPC) over the study period. The study conducted a detailed stratification based on gender, 20 age groups, 21 GBD regions, 204 countries and territories, and 5 SDI quintiles.

Results: In 2021, asthma continued to impose a substantial burden on the global health landscape, with a total of 260479186.9 (227209547.5-297967236.9) cases and an ASPR of 3340.1 (2905.2-3832.2 per 100,000 people. The ASIR was 37864175.4 (31381241-46919993.7), translating to 516.7 (425.4-646.1) per 100,000 people. In 2021, the number of disability-adjusted life years (DALYs) attributed to asthma was 21422859.9 (16956877.7-26887091.7), and the ASDR was 264.6 (208.3-333.4) per 100,000 people. Analyzing regional disparities, it was observed that High SDI regions had the highest ASPR, and ASIR, while Low SDI regions had the lowest ASDR and Age-standardized DALY rates. Geographically, Kazakstan and Pakistan stood out with the high ASPR, and Papua New Guinea stood out with the highest ASDR, and Age-standardized DALY rates. Asthma primarily affects minors, with no significant difference between males and females. High BMI has emerged as the most important risk factor for asthma-related DALYs globally.

Conclusion: This pattern indicates a complex relationship between socio-economic development and health outcomes. Regions with higher Socio-Demographic Index (SDI), which typically represent more developed areas, tend to have a higher prevalence of asthma but lower mortality rates and disease burden. These patterns highlight the necessity for low-income regions to learn from the targeted public health measures of high-income areas in developing asthma management plans, in order to address the inequalities in asthma outcomes.

1990年至2021年全球、区域和国家哮喘负担:2021年全球疾病负担数据分析
背景:哮喘是全球范围内严重威胁人类健康的疾病之一。1990年至2021年的全球疾病负担(GBD)研究对哮喘的患病率、发病率、死亡率和残疾调整生命年(DALY)进行了全面评估。这项研究特别侧重于将患病率数据与其他指标相结合,并根据性别、年龄和社会人口指数(SDI)在全球、区域和国家各级进行分层分析。方法:本研究的数据来自2021年全球疾病负担(GBD)研究,该研究提供了有关疾病、损伤和风险因素的综合数据。本研究旨在探讨哮喘的时间趋势,评估哮喘的年龄标准化患病率(ASPR)、发病率(ASIR)、死亡率(ASDR)和残疾调整生命年(DALYs)的动态,通过估算研究期间的年百分比变化(EAPC)来实现目标。该研究根据性别、20个年龄组、21个GBD地区、204个国家和地区以及5个SDI五分位数进行了详细的分层。结果:2021年,哮喘继续给全球健康格局带来沉重负担,共有260479186.9(227209547.5-297967236.9)例,ASPR为每10万人3340.1(2905.2-3832.2)例。ASIR为37864175.4(31381241-46919993.7),换算为每10万人516.7(425.4-646.1)。2021年,哮喘导致的残疾调整生命年(DALYs)为21422859.9 (16956877.7-26887091.7),ASDR为每10万人264.6(208.3-333.4)。分析区域差异,发现高SDI地区的ASDR和ASIR最高,而低SDI地区的ASDR和年龄标准化DALY率最低。从地理上看,哈萨克斯坦和巴基斯坦的ASDR较高,巴布亚新几内亚的ASDR和年龄标准化DALY率最高。哮喘主要影响未成年人,男女无显著差异。在全球范围内,高BMI已成为与哮喘相关的DALYs的最重要风险因素。结论:这一模式表明社会经济发展与健康结果之间存在复杂的关系。社会人口指数(SDI)较高的地区(通常代表较发达的地区)往往有较高的哮喘患病率,但死亡率和疾病负担较低。这些模式突出表明,低收入地区有必要在制定哮喘管理计划时借鉴高收入地区有针对性的公共卫生措施,以解决哮喘结果的不平等问题。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
BMC Pulmonary Medicine
BMC Pulmonary Medicine RESPIRATORY SYSTEM-
CiteScore
4.40
自引率
3.20%
发文量
423
审稿时长
6-12 weeks
期刊介绍: BMC Pulmonary Medicine is an open access, peer-reviewed journal that considers articles on all aspects of the prevention, diagnosis and management of pulmonary and associated disorders, as well as related molecular genetics, pathophysiology, and epidemiology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信